HPV vaccine and cervical screening: what you need to know
HPV, or human papillomavirus, is a group of common viruses. Some high-risk HPV types are related to higher risk of cervical, vaginal, and vulvar cancers. HPV infection is common, and most infections clear on their own, but persistent high-risk infection can lead to cervical cell changes.
What to know
- Normal variation exists, but screening and prevention still matter.
- Body signs can offer clues without confirming ovulation or diagnosis.
- Local clinical guidance should shape personal care decisions.
Start with the pattern
HPV, or human papillomavirus, is a group of common viruses. Some high-risk HPV types are related to higher risk of cervical, vaginal, and vulvar cancers. HPV infection is common, and most infections clear on their own, but persistent high-risk infection can lead to cervical cell changes.
Use the ideas below as general health context. Your own baseline, symptoms and daily functioning matter more than any single date, score or wearable sample.
How HPV relates to cervical cancer
Cervical health management usually includes two parts:
- HPV vaccination: lowers the risk of infection with certain high-risk HPV types.
- Cervical screening: uses HPV testing and/or Pap testing to find cell changes that could become precancerous.
HPV vaccination is not meaningful only at a very young age
CDC recommends routine HPV vaccination at ages 11-12, and it can start at age 9. Catch-up vaccination is generally recommended through age 26 for people not already vaccinated. For adults ages 27-45, vaccination should be discussed with a clinician based on individual risk, because many people have already been exposed to HPV and benefit varies.
Having had sex or having had one HPV type does not mean vaccination has no value. But the vaccine does not treat an existing infection or lesion. The decision is best made with a clinician based on age, vaccination history, partner context, and screening results.
When cervical screening starts
Guidelines differ by country and region. Based on CDC and ACOG information in the United States:
- Cervical cancer screening starts at age 21.
- Ages 21-29 usually use Pap testing.
- Ages 30-65 may use Pap testing, HPV testing, or co-testing, depending on clinician guidance.
Specific screening intervals should follow local medical guidelines and your clinician's advice.
What FlowHer can and cannot do
FlowHer can help you record periods, abnormal bleeding, discharge changes, pain, and screening reminders. It cannot replace HPV testing, Pap testing, colposcopy, or medical diagnosis.
If you notice bleeding after sex, repeated non-period bleeding, abnormal discharge, pelvic pain, or abnormal screening results, seek medical care promptly.
References
- Reducing risk for cervical cancerCenters for Disease Control and Prevention
- Cervical cancer screeningAmerican College of Obstetricians and Gynecologists
- Vulvovaginal healthAmerican College of Obstetricians and Gynecologists
- Your menstrual cycleOffice on Women's Health
Keep learning
Reproductive Health & Care
Ovulation body signs: discharge, temperature, and mild pain
Understand “Ovulation body signs: discharge, temperature, and mild pain” with evidence-aware context on personal patterns, the limits of single signals, and when to seek care.
3 min read
Reproductive Health & Care
Vaginal discharge and intimate care: what changes are normal?
Understand “Vaginal discharge and intimate care: what changes are normal?” with evidence-aware context on personal patterns, the limits of single signals, and when to seek care.
3 min read